Company / Current Assets
Adaptive Biotechnologies Corp Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$300.2M
FY2025
5-year range
$283.8M / $562.1M
FY2021-FY2025
Trend
+5.8%
vs FY2024
Sector context
#165 of 213
Health Care
What the data says
Adaptive Biotechnologies Corp's current assets of $300M is lower than 77% of companies in the Health Care sector (FY2025). Current Assets returned to growth in FY2025 after 2 years of decline, reaching $300M.
Based on SEC 10-K filings.
$300M in FY2025 with a 5-year CAGR of -16.2%.
Declined from $410M to $300M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -18.9%
- 5-Year CAGR
- -16.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 213This company $300.2M Sector average $2.5B
▼
-88.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -16.2%, indicating a declining trend.
- In FY2025, current assets increased 5.8% year-over-year.
- Ranks #165 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $300.2M | +5.8% |
| FY2024 | $283.8M | -30.8% |
| FY2023 | $410.2M | -27.0% |
| FY2022 | $562.1M | +39.6% |
| FY2021 | $402.7M | -44.6% |
| FY2020 | $726.9M | +18.6% |
| FY2019 | $612.7M | +239.0% |
| FY2018 | $180.7M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026